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Background: No studies on the risk factors of 2009 pandemic influenza A (H1N1) in China have been reported. We
aimed to investigate the risk factors for severe manifestations of 2009 pandemic H1N1 influenza in China
Methods: A case–control study with 343 severe hospitalized patients and 343 randomly selected mild controls was
conducted. The diagnosis was established by assessment of clinical symptoms and confirmed by the real-time
reverse-transcriptase-polymerase chain reaction assay. Severe or mild patients were classified by uniform criteria
issued by the Ministry of Health in China.
Results: The multivariable logistic regression analysis showed that the overweight or obese subjects admitted to
hospital with H1N1 influenza were more likely to experience severe manifestations. The ORs were 3.70 (95% CI:
2.04-6.72) and 35.61 (95% CI: 7.96-159.21) respectively. Subjects at age less than 5 years or older than 60 years had
an increased risk of severe manifestations (OR = 21.14, 95% CI: 7.79-57.33). We also observed increased risk among
subjects with longer time interval from symptom onset to hospital admission (OR = 3.26, 95% CI: 2.08-5.11) or
peasants (OR = 9.79, 95% CI: 5.11-18.78). Those with chronic disorders had increased risk of severe manifestations of
H1N1 influenza.
Conclusion: We provide evidence on the risk factors associated with severe manifestations of 2009 pandemic
H1N1 influenza in a study of hospitalized subjects in China.
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On June 11, 2009, the World Health Organization raised
the pandemic alert level of novel influenza A (H1N1) in-
fection to phase 6, indicating that a global pandemic had
begun [1]. The number of severe patients with pandemic
H1N1 influenza has increased rapidly. Up to April 25,
2010, the number of confirmed cases in China reached
127,788, with 8347 diagnosed with severe manifestations
and 803 deaths, representing a case fatality rate of 0.63%
[2]. Although initial reports suggested that the illness* Correspondence: xjwang62@163.com; bzq63@163.com
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reproduction in any medium, provided the orthat accompanied the 2009 pandemic H1N1 influenza
might be milder than the 1918 influenza pandemic, ser-
ious complications have been emerging continuously
[3,4]. Past studies from western countries have indicated
varied risk of severe manifestations of 2009 pandemic
H1N1 influenza associated with age, co-existence of
chronic diseases, pregnancy, and the time from symptom
onset to hospital admission, with particularly elevated
risk among elders, infants, pregnant women, subjects
with chronic disorders, immunosuppression, or delayed
hospital admission [4–9]. It holds significance to investi-
gate that whether these factors are associated with 2009
pandemic H1N1 influenza in China. A published study
conducted a two-year surveillance of 2009 pandemic
H1N1 influenza in Guangzhou, China and focused on
the epidemic tendency of H1N1 influenza. This study. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and death of cases with H1N1 influenza [10]. However,
no studies on the risk factors of severe manifestations
of 2009 pandemic H1N1 influenza in China have been
reported. Given the research status, we aimed to investigate
whether the major host characteristics and co-existence of
chronic diseases are associated with development of severe
manifestations of H1N1 infection in China.
In China, all suspicious novel pandemic H1N1 influ-
enza cases were reported to the Chinese Center for
Disease Control and Prevention (CDC) through a Na-
tional Influenza Surveillance Network. The cases were
then laboratory-confirmed under the auspices of the
Chinese CDC. Among those confirmed patients, cases
with severe manifestations were ascertained if satisfying
the criteria issued by the Ministry of Health in China
(please refer to the Materials and methods section for
details). A confirmed case who did not meet any of the
criteria was considered to be mild. Information on the
major characteristics was collected by using a standar-
dized case report form. We have access to all the hospi-
talized cases of H1N1 influenza in Shandong Province,
including 343 cases ascertained with severe disease and
3639 with mild manifestations.
In this study we investigated the risk factors of severe
manifestations of H1N1 influenza in a 1:1 matched case–
control study with all these 343 severe patients and 343
randomly selected mild controls.
Results
Information on the characteristics of study participants
is listed in Table 1. We compared the distribution of
these variables between cases (severe patients) and
controls (mild patients). Cases were more likely to be
infants or elders than controls. There was a trend
towards a higher prevalence of severe manifestations of
pandemic H1N1 influenza in females. Severe cases
tended to occur among peasants. We also observed a
higher percentage of participants with obesity, preg-
nancy, and chronic disorders among severe cases. More-
over, severe patients tended to have a longer time before
their hospital admission. The variables of age, occupa-
tion, body mass index (BMI), time from symptom onset
to hospitalization, co-existence of chronic respiratory
disease or diabetes, gender and pregnant status reached
statistical significance, and were included in the multi-
variable logistic regression model.
Multivariable analysis showed that the overweight or
obese subjects were more likely to experience severe man-
ifestations of pandemic H1N1 influenza; the ORs were
3.70 (95% CI: 2.04-6.72) and 35.61 (95% CI: 7.96-159.21)
respectively, compared with BMI less than 25.0. We
observed that subjects aged less than 5 years or older
than 60 years had a markedly increased risk of severemanifestations (OR 21.14, 95% CI 7.79-57.33). For age ≤5,
the OR (95% CI) was 17.41 (6.30-48.16). For age ≤60, all
the subjects were in the group of severe cases. We also
found significantly increased risk of severe disease among
subjects with a longer time interval from symptom onset
to hospital admission (OR = 3.26, 95% CI: 2.08-5.11) or
peasants (OR = 9.79, 95% CI: 5.11-18.78). Those with
chronic respiratory disease, diabetes and pregnant partici-
pants were associated with an increased risk of severe
manifestations of H1N1 influenza; the ORs were 42.98
(95% CI 5.24-352.55), 25.51 (95% CI 3.06-212.75), and
8.43 (95% CI 2.68-26.58) respectively (Table 2). We also
tested the potential interactions between risk factors on
risk of severe manifestations. However, no significant two-
way interaction terms were observed.
In the secondary analysis, we fitted models by stepwise
selection of the variables and the results revealed the
best performance of the same model as we used in the
primary analysis. A sensitivity analysis was also con-
ducted by enrolling all the variables in the univariate
analysis into the model; however, we did not see any
material change of the effect estimates for the major
variables that were included in the primary model.
Discussion
In this case control study of 2009 pandemic H1N1 infec-
tion among residents in Shandong Province, the pregnant
women, those with co-morbidities of chronic diseases,
and a longer interval from symptom onset to first visit of
hospital had markedly increased risk of severe manifesta-
tions of pandemic H1N1 influenza. In addition, peasants
had particularly higher risk of severe manifestations com-
pared with other occupational groups, which may hold
public health significance.
Li T. et al. reported that the scale and duration of out-
breaks, and fatality rates of 2009 pandemic H1N1 influ-
enza were significantly decreased in the second epidemic
year compared with those in the first epidemic year
(May 2009-April 2010), but similar to those of seasonal
influenza [10]. In consistent with the epidemic tendency
found in this study, we also chose April of 2010 as the
end time of inclusion in our analysis.
Obesity has been previously reported to be associated
with severe manifestations of H1N1 influenza [11–13].
Our study added to the previous report by comparing se-
vere hospitalized patients with mild patients in China. Even
if obesity may be only a proxy measure for other under-
lying conditions, BMI is an easily obtainable measurement
that may be useful for quickly identifying severe patients to
target for treatment and prevention measures [4].
In our study, severe manifestations of pandemic H1N1
influenza were associated with the presence of clinical
co-morbidities, such as chronic respiratory disease and
diabetes. Our results concurred with data from the United
Table 1 Characteristics of study participants by severity of manifestations from 2009 H1N1 Influenza, as reported to
the Shandong Center for disease control and prevention, China, during the period from May 13, 2009 to March 31,
2010
Characteristics Severe cases Mild cases P*
n=343 n=343
Age (years) (%)
≤5 28 (8.2) 5 (1.5) <0.001
>5 and <60 290 (84.5) 338 (98.5)
≥60 25 (7.3) 0
Gender (%)
Female 190 (55.4) 142 (41.4) <0.001
Male 153 (44.6) 201 (58.6)
Ethnic groups (%)
Han Chinese 337 (98.2) 339 (98.8) 0.52
Others 6 (1.8) 4 (1.2)
Occupation (%)
Peasant 138 (40.2) 14 (4.1) <0.001
Others 205 (59.8) 329 (95.9)
Body mass index (kg/m2) (%)
<18.5 45 (13.1) 85 (24.8) <0.001
18.5~24.9 151 (44.0) 233 (67.9)
25.0~29.9 97 (28.3) 23 (6.7)
≥30 50 (14.6) 2 (0.6)
Chronic coexisting illness (yes, %)
Chronic respiratory disease 30 (8.9) 1 (0.3) <0.001
Diabetes 20 (6.0) 1 (0.3) <0.001
Chronic renal disease 10 (2.9) 0 0.002
Chronic liver disease 8 (2.4) 0 0.007
Cancer or tumor 6 (1.8) 0 0.03
Chronic cardiac disease 46 (13.5) 0 <0.001
Immunosuppressive disorder 9 (2.9) 0 0.004
Pregnant status (yes, %) 72 (21.0) 4 (1.2) <0.001
Time from symptom onset to hospital admission (days) (%)
≤2 144 (42.0) 229 (66.8) <0.001
>2 180 (52.5) 83 (24.2)
Missing 19 (5.5) 31 (9.0)
Receiving seasonal influenza vaccination one year before onset (yes, %) 3 (1.2) 5 (1.7) 0.48
* χ2 test or Fisher’s exact test.
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70% of H1N1 patients with at least one concomitant
chronic disease, such as asthma, other lung diseases, and
diabetes, as well the data from a Chinese study, which
showed the fatal cases of pandemic H1N1 influenza asso-
ciated with chronic pulmonary disease [10]. For hospital-
ized patients of suspected or confirmed influenza with
other concomitant complications, current interim guide-
lines of Chinese CDC for pandemic and seasonal influenzarecommend the use of either oseltamivir or zanamivir for
treatment [15].
Pregnant women have been reported to exhibit in-
creased risk of seasonal or pandemic influenza and
influenza-associated complications in previous reports
[16–20]. During the 1918 influenza pandemic, the over-
all disease-specific mortality rate in pregnant women
was 27%, suggesting the significance of pregnancy for
severe manifestations during the influenza pandemics
Table 2 Association of selected characteristics with severe manifestations of H1N1 influenza
Risk factors Univariate analysis Multivariable analysis*
OR 95% CI OR 95% CI
Age (years)
>5 and <60 1.00 1.00
≤5 or ≥60 12.35 4.87-31.32 21.14 7.79-57.33
Occupation
Others 1.00 1.00
peasant 15.82 8.89-28.16 9.79 5.11-18.78
Body mass index (kg/m2)
< 25.0 1.00 1.00
25.0~29.9 6.84 4.20-11.15 3.70 2.04-6.72
≥30.0 40.56 9.76-168.57 35.61 7.96-159.21
Chronic respiratory disease
No 1.00 1.00
Yes 32.78 4.44-241.79 42.98 5.24-352.55
Diabetes
No 1.00 1.00
Yes 21.18 2.83-158.70 25.51 3.06-212.75
Gender/pregnancy
Male 0.89 0.64-1.23 0.66 0.43-1.02
Female, no 1.00 1.00
Female, yes 21.05 7.47-59.34 8.43 2.68-26.58
Time from symptom onset to hospital admission (days)
≤2 1.00 1.00
>2 3.45 2.47-4.81 3.26 2.08-5.11
* Logistic regression model, adjusting for other risk factors listed in the table simultaneously.
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between pregnancy and the current pandemic of H1N1
influenza, and showed that patients or clinicians may
want to avoid antiviral treatment due to concerns about
the fetus [6]. Consistent with these studies, pregnancy
was associated with severe manifestations of H1N1 in-
fluenza in our study. Given the research evidence, clini-
cians may consider screening pregnant patients with
suspected influenza or pneumonia, with the aim of initi-
ating treatment immediately after onset of symptoms.
Pregnant and postpartum women should be encouraged
to receive vaccination for influenza [21,22].
Past evidences showed that seasonal influenza hospitali-
zations are more common among persons at advanced
ages or under 5 years [23]. In Mexico, a retrospective
study found that the disease tended to be more severe in
infants and those older than 60 years than in other age-
groups [5]. Past evidence also showed that hospitalized
patients with pandemic H1N1 influenza aged 50 years or
older were most likely to die [4]. Consistent with these
evidence, our study found increased risk of severe mani-
festations of H1N1 influenza among those at advancedage or age under 5 years, suggesting a possible U-shape
relationship with age. We observed significantly increased
risk for age less than 5 years. For age more than 60 years,
all the subjects went to the group with severe manifesta-
tions, which supported the higher risk of severe manifesta-
tions among those at advanced aged. Clinicians should
closely monitor and promptly treat younger or older hos-
pitalized patients with H1N1 infection.
The significant associations of severe manifestations of
pandemic H1N1 influenza with pregnancy and other
chronic complications are worth further investigation.
Pregnant women may be more likely to be admitted for
observation even with less severe symptoms than non-
pregnant women. Subjects with diabetes or other respira-
tory diseases might also be more likely to be admitted
even with mild influenza-related manifestations; therefore
a lower OR for severe manifestations of H1N1 influenza
among these subjects could be expected from this per-
spective. However, previous reports have shown that the
pregnant cases tended to deteriorate [6]. It is worth noting
that the cases were comprehensively defined as having
severe manifestations based on the symptoms presented
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of the admission. Interpretation of the results requires
caution.
Peasants were at significantly elevated risk of severe
influenza, which may be due to the relatively lower so-
cioeconomic status, limited health awareness and acces-
sibility of rural residents to health care facilities. These
data may have implications for public health at the com-
munity level. Health education and promotion should
be strengthened in rural areas.
This study is limited by its retrospective case–control
design of cases only. Cases were drawn from hospitalized
inpatients, whereas controls were drawn from patients
with mild manifestations of H1N1 influenza. Potential
selection and information bias is likely due to the study
design. The control selection of mild patients rather
than healthy population would have resulted in conser-
vative estimates of ORs for the potential risk factors.
Our sample size is only moderate, which limits the fur-
ther exploration of the associated factors. We lack suffi-
cient power to provide the OR specifically for those at
age ≥60 years. However, we included all the cases with
severe manifestations of H1N1 influenza in Shandong
Province, and selected controls based on a pre-designed
1:1 case control study. The selected controls (mild cases)
were very similar in the distribution of the major charac-
teristics with the total 3639 mild cases in Shandong. We
cannot evaluate several chronic diseases further except
for chronic respiratory diseases and diabetes. However,
even among the total 3639 mild patients, we did not find
one patient with actively other chronic disorders. Cases
with obvious aggravation of previous chronic diseases
were assessed as severe cases. The frontline health pro-
fessionals therefore could tend to diagnose those with
concomitant chronic disorders as severe cases. As an ob-
servational study, we cannot rule out the possibility of
residual confounding by unmeasured or imperfectly
measured risk factors. We lacked information on some
potentially important factors, such as the history of close
contact and medication uses.
Conclusions
In conclusion, our case control study has provided evi-
dence on the risk factors associated with severe manifes-
tations of hospitalized patients with pandemic H1N1
influenza in China. Further studies are warranted to
confirm our findings.
Materials and methods
Data sources
In China, all suspicious 2009 pandemic H1N1 influenza
cases are reported to the Chinese CDC through a National
Influenza Surveillance Network. Throat swab specimens
were collected for each participant, and then sent to theNetwork. Cases were then laboratory-confirmed by
the positive results on a real-time reverse-transcriptase-
polymerase chain reaction assay performed under the
auspices of the Chinese CDC.
Among these confirmed patients, cases with severe
manifestations were defined as having at least one of the
following symptoms: 1) persistent fever for >3 days; 2) se-
vere coughing with purulent sputum, bloody sputum, or
chest pain; 3) rapid breathing, breathing difficulty and
lip cyanosis; 4) altered mental status, such as slow re-
sponse, hypersomnia, dysphoria and convulsions; 5) heavy
vomiting, diarrhea and signs of dehydration; 6) signs of
pneumonia in imaging examinations; 7) rapidly elevated
levels of cardiac enzymes such as creatine kinase and cre-
atine kinase-MB increasing rapidly; and 8) the obvious
aggravation of previous chronic diseases [15]. A confirmed
case who did not meet any of the above criteria was con-
sidered to be a mild patient. We collected information
on the main demographic variables (age, sex, occupation
and ethnic groups), BMI (defined as weight divided by
square of height, kg/m2), time from symptom onset to
hospital admission, receiving seasonal influenza vaccin-
ation one year before onset of H1N1 influenza (yes or no),
co-existence of chronic diseases (chronic pulmonary dis-
eases, diabetes, renal diseases, chronic cardiac disease,
immunosuppressive disorder, or cancer) and pregnant sta-
tus (yes or no) in occurrence of H1N1 influenza. Chronic
pulmonary diseases included asthma, chronic bronchitis,
tuberculosis, emphysema, chronic obstructive pulmonary
disease and tuberculosis pleurisy. All these information
was collected by a standardized case report form issued by
the Ministry of Health in China. This form was applied to
each case within 24 h after the clinical outcome (disease
cure or death). All case report forms were filled by the
frontline physicians in the hospitals responsible for diag-
nosis and treatment of H1N1 influenza designated by the
local CDC in Shandong Province. The face-to-face inter-
views were conducted, and information from the medical
records was reviewed to help double-check the surveys.
All the surveyors were strictly trained for the survey, to
ensure that they conducted the interviews according to
uniform standards and methods.
We have access to all the patients of H1N1 influenza
in Shandong Province. Totally we identified 3982 cases
between May 13, 2009 and March 31, 2010, by China
novel influenza A (H1N1) surveillance system from
Shandong Province. We chose April of 2010 as the end
time of inclusion because the incidence of H1N1 influ-
enza in China began to fall to a low level since then with
less than 30 confirmed cases per week. A total of 343
cases were ascertained with severe disease, while 3639
with mild manifestations. Random number method was
applied to sample 343 from the total cases with mild
manifestations. These were included as controls in our
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characteristics. For time from symptom onset to hospital
admission, we have information for 324 cases of severe
manifestations (94.5%), and 312 of mild manifestations
(91.0%). We found very similar distribution of the major
demographic factors between all the 3639 mild patients
and these selected 343 controls.
Statistical analysis
According to the distribution of the characteristics, the
occupation status was reclassified into two categories
(peasant or others). BMI was classified into four categories
[underweight (<18.5 kg/m2), normal (18.5~24.9 kg/m2),
overweight (25.0~29.9 kg/m2), or obese (≥30 kg/m2). Time
from symptom onset to hospitalization was classified as
two categories (≤2 or >2 days). For initial screening of po-
tential risk factors, we applied univariate analysis by using
χ2 test or Fisher’s exact test to compare the distribution
of different variables in the above-mentioned categories
between severe and mild patients, including age, sex, eth-
nic groups, occupation, BMI, time from symptom onset to
hospitalization, chronic coexisting illness, pregnancy status,
and seasonal influenza vaccination one year before onset.
We compared the distribution of each characteristic
between cases and controls. For variables reaching
statistical significance (P <0.05), we then carried out uni-
variate and multivariable-adjusted analysis to estimate
the odds ratio (ORs) and corresponding 95% confidence
intervals (CIs) for associations of potential risk factors
with severe manifestations of H1N1 influenza. Among
patients with renal disease, chronic liver disease, chronic
cardiac disease, cancer or immunosuppressive disorders,
we found no participants with mild H1N1 influenza.
Therefore we did not include these chronic diseases in
the multivariable regression analysis. For participants
aged more than 60 years, there are no subjects in the
control group. Therefore for the variable age, we com-
bined the category “<5 years” with “≥60 years”, given the
past evidence which showed a higher risk of severe
influenza in infants and elder people. To evaluate the
risk for overweight or obese subjects, the BMI category
of “underweight” was combined with “normal”. We de-
rived a new variable to merge sex and pregnancy status
to avoid co-linearity of the model, with three categories
(men, women without pregnancy, or women with preg-
nancy) and women without pregnancy as the reference
group. For the variables with missing data (time from
symptom onset to hospital admission), we created an
indicator variable for the missing category.
To check the validity of the model, we fitted models
by forward stepwise selection of the variables. We also
conducted a sensitivity analysis by enrolling all the vari-
ables in the univariate analysis into the multivariable
regression model.We conducted all statistical analyses using SAS software
(v9.1; SAS Institute Inc, Cary, NC). All statistical tests
were 2-tailed, and the significance level was set at P <0.05.
The study was approved by the Institutional Review
Board at the Shandong University School of Public Health.
All participants had been aware that information was
being collected for the purpose of future series of research
and provided written informed consent for participating
in these studies. Therefore for the current specific ana-
lysis, the Institutional Review Board waived the need for
further consent to participate.
Abbreviations
BMI: Body mass index; CI: Confidence interval; CDC: Center for Disease
Control and Prevention; OR: Odds ratio.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
XJW and ZQB have full access to all of the data in the study and take
responsibility for the integrity of the data and the accuracy of the data
analysis. XJW and ZQB conceived of the study. YYR, YYY, WQL, XJW and ZQB
participated in its design and coordination. XJW and ZQB acquired the data.
YYY performed the statistical analysis. YYR, YYY, WQL, YL, TL, SW, SZ, and ZL
prepared the first draft of the manuscript while YYR and WQL made critical
revisions to it. All authors read and approved the final manuscript.
Funding
The study was supported by Science and Technology Development Plan
(first batch) Medical Project (2009GG10002054) of Shandong Province, 2009.
Author details
1Shandong Center for Disease Prevention and Control, Jinan, Shandong
Province, China. 2Shandong Provincial Key Laboratory of Infectious Disease
Control and Prevention, Jinan, Shandong Province, China. 3Shandong
Institute for Endemic Diseases Control and Research, Jinan, Shandong
Province, China. 4Brigham and Women’s Hospital, Harvard Medical School,
Boston, MA, USA. 5Shandong University School of Public Health, Jinan,
Shandong Province, China.
Received: 3 March 2012 Accepted: 9 May 2013
Published: 15 May 2013
References
1. World Health Organization: Global alert and response, pandemic (H1N1) 2009,
frequently asked questions: what is phase 6? [WHO Web site]. June 11. 2009.
Available at: [http://www.who.int/csr/disease/swineflu/
frequently_asked_questions/levels_pandemic_alert/en/index.html]. Accessed
August 10, 2011.
2. Chinese Center for Disease Control and Prevention: Influenza weekly report
NO.71. Beijing; 2009. [http://www.cnic.org.cn/] (internal use only).
3. Cao B, Li XW, Mao Y, et al: Clinical Features of the Initial Cases of,
Pandemic Influenza A (H1N1) Virus Infection in China. N Engl J Med 2009,
2009(361):2507–2517.
4. Louie JK, Acosta M, Winter K, et al: Factors Associated With Death or
Hospitalization Due to Pandemic, Influenza A(H1N1) Infection in
California. JAMA 2009, 2009(302):1896–1902.
5. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, et al: Infection and
death from influenza A H1N1 virus in Mexico: a retrospective analysis.
Lancet 2009, 374:2072–2079.
6. Louie JK, Acosta M, Jamieson DJ, et al: Severe, 2009 H1N1 Influenza in
Pregnant and Postpartum Women in California. N Engl J Med 2010,
2010(362):27–35.
7. The ANZIC Influenza Investigators and Australasian Maternity Outcomes
Surveillance System: Critical illness due to 2009 A/H1N1 influenza in
pregnant and postpartum women: population based cohort study.
BMJ 2010, 340:c1279.
Ren et al. Virology Journal 2013, 10:149 Page 7 of 7
http://www.virologyj.com/content/10/1/1498. Zarychanski R, Stuart TL, Kumar A, et al: Correlates of severe disease in
patients with 2009 pandemic influenza (H1N1) virus infection.
CMAJ 2010, 182:257–264.
9. Palacios G, Hornig M, Cisterna D, et al: Streptococcus pneumoniae
coinfection is correlated with the severity of H1N1 pandemic influenza.
PLoS One 2009, 4:e8540.
10. Li T, Fu C, Di B, Wu J, et al: A Two-Year Surveillance of 2009 Pandemic
Influenza A (H1N1) in Guangzhou, China: From Pandemic to Seasonal
Influenza? PLoS One 2011, 6:e28027.
11. Jain S, Kamimoto L, Bramley AM, et al: Hospitalized patients with, H1N1
influenza in the United States April-June 2009. N Engl J Med 2009,
2009(361):1935–1944.
12. O'Riordan S, Barton M, Yau Y, et al: Risk factors and outcomes among
children admitted to hospital with pandemic H1N1 influenza. CMAJ 2010,
182:39–44.
13. Centers for Disease Control and Prevention (CDC): Intensive-care patients
with severe novel influenza A (H1N1) virus infection-Michigan, June
2009. MMWR Morb Mortal Wkly Rep 2009, 58:749–752.
14. Mangtani P, Mak TK, Pfeifer D: Pandemic H1N1 infection in pregnant
women in the USA. Lancet 2009, 374:429–430.
15. Ministry of Health, China: Influenza A (H1N1) diagnosis and treatment
program (third edition 2009). [China MOH Web site]. October 13. 2009.
Available at: [http://www.moh.gov.cn/mohwsyjbgs/s9990/200910/43111.
shtml]. Accessed May 16, 2013.
16. Jamieson DJ, Honein MA, Rasmussen SA, et al: H1N1 2009 influenza virus
infection during pregnancy in the USA. Lancet 2009, 374:451–458.
17. Dodds L, McNeil SA, Fell DB, et al: Impact of influenza exposure on rates
of hospital admissions and physician visits because of respiratory illness
among pregnant women. CMAJ 2007, 176:463–468.
18. Neuzil KM, Reed GW, Mitchel EF, et al: Impact of influenza on acute
cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol
1998, 148:1094–1102.
19. Freeman DW, Barno A: Deaths from Asian influenza associated with
pregnancy. Am J Obstet Gynecol 1959, 78:1172–1175.
20. Harris JW: Influenza occurring in pregnant women. JAMA 1919, 72:978–980.
21. World Health Organization: Experts advise WHO on pandemic vaccine policies
and strategies. Pandemic (H1N1) 2009 briefing note 14. [WHO Web site].
October 30. 2009. Available at: [http://www.who.int/csr/disease/swineflu/
notes/briefing_20091030/en/index.html]. Accessed August 10, 2011.
22. Zaman K, Roy E, Arifeen SE, et al: Effectiveness of maternal influenza
immunization in mothers and infants. N Engl J Med 2008, 359:1555–1564.
23. Thompson WW, Shay DK, Weintraub E, et al: Influenza-associated
hospitalizations in the United States. JAMA 2004, 292:1333–1340.
doi:10.1186/1743-422X-10-149
Cite this article as: Ren et al.: Risk factors associated with severe
manifestations of 2009 pandemic influenza A (H1N1) infection in China:
a case–control study. Virology Journal 2013 10:149.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
